Explore

Trendline Trendline
Syneron Bio Secures $150 Million to Advance Macrocyclic Peptide Development

Syneron Bio Secures $150 Million to Advance Macrocyclic Peptide Development

Syneron Bio Secures $150 Million to Advance Macrocyclic Peptide Development
Trendline Trendline
Scala Biodesign Secures $16M to Expand AI-Driven Protein Development

Scala Biodesign Secures $16M to Expand AI-Driven Protein Development

Scala Biodesign Secures $16M to Expand AI-Driven Protein Development
Trendline Trendline
Biotech Company Immunai Develops AI-Powered Immune Atlas to Enhance Drug Efficacy

Biotech Company Immunai Develops AI-Powered Immune Atlas to Enhance Drug Efficacy

Biotech Company Immunai Develops AI-Powered Immune Atlas to Enhance Drug Efficacy
Trendline Trendline
AI in Life Sciences Market Projected to Transform Drug Development and Clinical Trials

AI in Life Sciences Market Projected to Transform Drug Development and Clinical Trials

AI in Life Sciences Market Projected to Transform Drug Development and Clinical Trials
Trendline Trendline
Biotech Company Scala Biodesign Secures $16M to Expand AI-Driven Protein Development

Biotech Company Scala Biodesign Secures $16M to Expand AI-Driven Protein Development

Biotech Company Scala Biodesign Secures $16M to Expand AI-Driven Protein Development
Trendline Trendline
Oncology Drug Development: Streamlined Preclinical Toxicology for Faster IND Submissions

Oncology Drug Development: Streamlined Preclinical Toxicology for Faster IND Submissions

Oncology Drug Development: Streamlined Preclinical Toxicology for Faster IND Submissions
Trendline Trendline
Dyno Therapeutics Licenses AI-Designed Capsid to Astellas for Muscle Gene Therapy

Dyno Therapeutics Licenses AI-Designed Capsid to Astellas for Muscle Gene Therapy

Dyno Therapeutics Licenses AI-Designed Capsid to Astellas for Muscle Gene Therapy
Trendline Trendline
Augmented Intelligence Revolutionizes Biopharma Innovation Amidst Investment Challenges

Augmented Intelligence Revolutionizes Biopharma Innovation Amidst Investment Challenges

Augmented Intelligence Revolutionizes Biopharma Innovation Amidst Investment Challenges
Trendline Trendline
AI-Driven BioGPU Technology Revolutionizes Cellular Biology Research

AI-Driven BioGPU Technology Revolutionizes Cellular Biology Research

AI-Driven BioGPU Technology Revolutionizes Cellular Biology Research
Trendline Trendline
OneCyte and Kemp Proteins Partner to Enhance Cell Line Development with AI

OneCyte and Kemp Proteins Partner to Enhance Cell Line Development with AI

OneCyte and Kemp Proteins Partner to Enhance Cell Line Development with AI
Trendline Trendline
enGene Rebrands to enGene Therapeutics, Signaling Shift Towards Commercialization

enGene Rebrands to enGene Therapeutics, Signaling Shift Towards Commercialization

enGene Rebrands to enGene Therapeutics, Signaling Shift Towards Commercialization
Trendline Trendline
Biopharma Companies Leverage Augmented Intelligence to Enhance Innovation and Investment Confidence

Biopharma Companies Leverage Augmented Intelligence to Enhance Innovation and Investment Confidence

Biopharma Companies Leverage Augmented Intelligence to Enhance Innovation and Investment Confidence